As of 12:30 PM on the 16th, Jinwon Life Sciences is trading at 28,500 KRW, up 10.68% from the previous day. This represents a 190.22% increase compared to August 19. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners have a tentative net purchase of 187,100 shares of Jinwon Life Sciences, and institutions have a net purchase of 11,000 shares. Over the past five days, individual investors have net sold 182,452 shares, while foreigners and institutions have net bought 186,447 shares and net sold 3,574 shares, respectively.


On September 10, Jinwon Life Sciences became a market topic with the news of the 'Inovio COVID-19 vaccine candidate 100 million dose production agreement...'





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing